EUVIMEDEUVIMED entdecken
Crossref

Elucidating the efficacy and mechanism of Ginkgo biloba extract in treating hyperuricemic nephropathy using network pharmacology, metabolomics, gut microbiota analysis, and experimental validation

Li He, Chen Li, Yue Zhang, Nan Zhang, Junjie Cai, Xinxue Xu, Wangwei Lv, Hailin Wei, Junliang Dong, Erbing Wang, Tingli Qu

Journal of Pharmacy and Pharmacology · 2026

DOI: 10.1093/jpp/rgag064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2026. Verfasst von Li He und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Management, Shanxi Medical University, Taiyuan, Shanxi 030001, PR China. Hauptthemen laut MEDLINE: Hyperuricemia, Plant Extracts, Gastrointestinal Microbiome, Kidney Diseases. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Shanxi Provincial Health Commission Traditional Chinese Medicine Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although Ginkgo biloba extract (GBE) has been used to treat nephropathy, its effects and underlying mechanisms in hyperuricemic nephropathy (HN) remain unclear.

Methods

Based on biochemical parameters, inflammatory markers, and renal histopathological morphology, this study employed a rat HN model to examine the impact of GBE. Subsequently, an integrated strategy—combining network pharmacology, renal metabolomics, and gut microbiota profiling—was implemented to probe the mechanistic basis. Finally, Molecular dynamics (MD), molecular dynamic simulations, polymerase chain reaction (PCR), immunohistochemistry (IHC), and xanthine dehydrogenase (XDH) inhibits were applied to elucidate the mechanisms.

Results

The similarity of fingerprint profiles of three batches of GBE was >0.95, with flavonoid and lactone contents of 29.94% and 13.78%, respectively, meeting the requirements of the Chinese Pharmacopeia standards. GBE intervention led to improved renal function, lowered concentrations of uric acid (UA), interleukin-1 beta, and interleukin-6, and alleviated renal injury. It also regulated purine metabolism and gut microbiota. Notably, quercetin in GBE strongly inhibited xanthine dehydrogenase, as confirmed by its low binding energy and reduced renal expression.

Conclusions

GBE alleviates HN through a dual mechanism: by targeting the purine metabolism pathway to inhibit UA production and by modulating the gut microbiota to restore homeostasis. These findings provide insights into the molecular mechanisms underlying the therapeutic effects of traditional Chinese medicine in HN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperuricemiaPlant ExtractsGastrointestinal MicrobiomeKidney DiseasesAnimalsGinkgo bilobaMetabolomicsMaleNetwork PharmacologyRatsKidneyUric AcidRats, Sprague-DawleyGinkgo ExtractDisease Models, AnimalXanthine Dehydrogenase

Stichwörter der Autor:innen

Ginkgo biloba extractfecal gut microbiotahyperuricemic nephropathymetabolomicsnetwork pharmacology

Substanzen

Plant ExtractsUric AcidGinkgo ExtractGinkgo biloba extractXanthine Dehydrogenase

Autor:innen und Institutionen

  • School of Management, Shanxi Medical University, Taiyuan, Shanxi 030001, PR China.
  • School of Pharmacy, Shanxi Medical University, Taiyuan, Shanxi 030001, PR China.
  • Shanxi Huakang Pharmaceutical Co., Ltd., Yuncheng, Shanxi 044200, PR China.
  • College of Chemical Engineering and Technology, Taiyuan University of Science and Technology, Taiyuan, Shanxi 030024, PR China.

Förderung

  • Shanxi Provincial Health Commission Traditional Chinese Medicine Research Project

Zitieren

APA

He, L., Li, C., Zhang, Y., Zhang, N., Cai, J., Xu, X., Lv, W., Wei, H., Dong, J., Wang, E., & Qu, T. (2026). Elucidating the efficacy and mechanism of Ginkgo biloba extract in treating hyperuricemic nephropathy using network pharmacology, metabolomics, gut microbiota analysis, and experimental validation. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgag064

Vancouver

He L, Li C, Zhang Y, Zhang N, Cai J, Xu X, et al. Elucidating the efficacy and mechanism of Ginkgo biloba extract in treating hyperuricemic nephropathy using network pharmacology, metabolomics, gut microbiota analysis, and experimental validation. Journal of Pharmacy and Pharmacology. 2026. doi:10.1093/jpp/rgag064

BibTeX
@article{He2026,
  author = {He, Li and Li, Chen and Zhang, Yue and Zhang, Nan and Cai, Junjie and Xu, Xinxue and Lv, Wangwei and Wei, Hailin and Dong, Junliang and Wang, Erbing and Qu, Tingli},
  title = {Elucidating the efficacy and mechanism of Ginkgo biloba extract in treating hyperuricemic nephropathy using network pharmacology, metabolomics, gut microbiota analysis, and experimental validation},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2026},
  doi = {10.1093/jpp/rgag064}
}
Kostenlos starten →